User profiles for K. Chalkidou

Kalipso Chalkidou

Global Fund to Fight AIDS TB and Malaria
Verified email at imperial.ac.uk
Cited by 10491

Evidence for overuse of medical services around the world

S Brownlee, K Chalkidou, J Doust, AG Elshaug… - The Lancet, 2017 - thelancet.com
Overuse, which is defined as the provision of medical services that are more likely to cause
harm than good, is a pervasive problem. Direct measurement of overuse through …

NCD Countdown 2030: pathways to achieving Sustainable Development Goal target 3.4

…, V Kontis, CD Mathers, M Guillot, J Rehm, K Chalkidou… - The Lancet, 2020 - thelancet.com
The Sustainable Development Goal (SDG) target 3.4 is to reduce premature mortality from
non-communicable diseases (NCDs) by a third by 2030 relative to 2015 levels, and to …

How to formulate research recommendations

P Brown, K Brunnhuber, K Chalkidou, I Chalmers… - Bmj, 2006 - bmj.com
… Kalipso Chalkidou, associate director, research and development2, … Brown P, Brunnhuber
K, Chalkidou K, Chalmers I, Clarke M, Fenton M et al. … Articles by Kalipso Chalkidou

A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers

…, E Bergel, I Harvey, DJ Magid, K Chalkidou - Journal of clinical …, 2009 - Elsevier
OBJECTIVE: To propose a tool to assist trialists in making design decisions that are consistent
with their trial's stated purpose. STUDY DESIGN AND SETTING: Randomized trials have …

NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4

…, ME Kruk, LM Riley, K Dain, AP Kengne, K Chalkidou… - The lancet, 2018 - thelancet.com
The third UN High-Level Meeting on Non-Communicable Diseases (NCDs) on Sept 27, 2018,
will review national and global progress towards the prevention and control of NCDs, and …

Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries

K Chalkidou, P Marquez, PK Dhillon… - The lancet …, 2014 - thelancet.com
Evidence-informed frameworks for cost-effective cancer prevention and management are
essential for delivering equitable outcomes and tackling the growing burden of cancer in all …

An introduction to the main types of economic evaluations used for informing priority setting and resource allocation in healthcare: key features, uses, and limitations

…, LE Downey, W Isaranuwatchai, K Chalkidou… - Frontiers in public …, 2021 - frontiersin.org
Economic evidence is increasingly being used for informing health policies. However, the
underlining principles of health economic analyses are not always fully understood by non-…

[HTML][HTML] Priority-setting for achieving universal health coverage

K Chalkidou, A Glassman, R Marten… - Bulletin of the World …, 2016 - ncbi.nlm.nih.gov
Governments in low-and middle-income countries are legitimizing the implementation of
universal health coverage (UHC), following a United Nation’s resolution on UHC in 2012 and its …

Comparative effectiveness research and evidence‐based health policy: experience from four countries

K Chalkidou, S Tunis, R Lopert, L Rochaix… - The Milbank …, 2009 - Wiley Online Library
Context: The discussion about improving the efficiency, quality, and long‐term sustainability
of the US health care system is increasingly focusing on the need to provide better evidence …

The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research

K Chalkidou, S Tunis, D Whicher, R Fowler… - Clinical …, 2012 - journals.sagepub.com
… ‘PRACTIHC Canada’, and Kalipso Chalkidou was supported by a Commonwealth Fund
grant… Tunis SR, Chalkidou K. Coverage with evidence development: A very good beginning, but …